ADC Therapeutics SA (ADCT) Net margin 2022–2025
ADC Therapeutics SA (ADCT) net profit margin by fiscal year — reported net income divided by reported revenue.
-175.3%FY2025 · since FY2022: -209.8% → -175.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -175.3% | +47.5 pp |
| FY2024 | -222.8% | +124.8 pp |
| FY2023 | -347.6% | -137.8 pp |
| FY2022 | -209.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →